This refers to tumors or growths in the brain, spinal cord, or covering around them. These can be non-cancerous (benign) or cancerous (malignant).
Every report comes from a Lived member, sent anonymously.
Have you had Craniotomy for CNS Neoplasms?
Central nervous system (CNS) neoplasms are tumors of the brain and spinal cord, which together make up the central nervous system. A tumor forms when abnormal cells keep growing into a mass. Some are benign (not cancer) and grow slowly; others are malignant (cancer) and can grow quickly into surrounding brain tissue. Because the skull and spinal canal leave little spare room, even a benign tumor can cause serious problems by pressing on nearby tissue, so both kinds usually need medical care. Symptoms depend mostly on where the tumor sits and how fast it grows. Rising pressure inside the skull can cause headaches that worsen over time, nausea or vomiting, blurred vision, drowsiness or seizures. A tumor can also disrupt whatever the nearby area controls, such as strength or feeling on one side of the body, speech, balance, vision, hearing, or thinking and personality. Spinal cord tumors more often cause back pain, numbness or weakness in the arms or legs, and changes in bladder or bowel control. The term covers many different diseases. Primary tumors start in the brain or spinal cord; common types include gliomas (such as astrocytoma and glioblastoma), meningiomas, which grow from the membranes covering the brain, pituitary tumors and schwannomas. Metastatic brain tumors begin as cancer elsewhere in the body, most often the lung, and spread to the brain. They are more common than primary tumors and are treated as part of that original cancer. The specific type and grade of a tumor shape almost everything that follows.
For most people with a brain or spinal cord tumor, no cause is ever found, and nothing they did or avoided is known to have brought it on. Researchers have identified only a few clear risk factors. The best-established environmental one is radiation to the head, most often radiation therapy given years earlier for another cancer. These tumors usually appear 10 to 15 years after treatment and are rare; for most people who need that radiation, its benefits far outweigh this later risk. Imaging tests such as CT (computed tomography) scans use much lower doses, and any added risk from them is likely very small. A small share of tumors occur in people with inherited syndromes that raise the risk of several tumor types, including neurofibromatosis type 1 and type 2, tuberous sclerosis, von Hippel-Lindau disease and Li-Fraumeni syndrome. In these families, tumors tend to appear at younger ages. A weakened immune system, as with AIDS (acquired immunodeficiency syndrome) or the medicines taken after an organ transplant, raises the risk of one specific type, primary CNS lymphoma. Many people wonder about cell phones. Most of the larger studies have not found that cell phone use raises brain tumor risk, although research continues. Links to chemicals such as vinyl chloride, used in making plastics, have been inconsistent across studies.
Assessment starts with a description of the symptoms and a neurological exam, which checks strength, sensation, reflexes, coordination, walking, vision and thinking. The pattern of findings helps point to where in the nervous system the problem lies. MRI (magnetic resonance imaging) is the main test. It uses a magnet and radio waves rather than X-rays, and a contrast dye called gadolinium, given into a vein, makes many tumors stand out more clearly. It is the preferred test for the spinal cord. A CT scan is faster and is often used when someone needs a quick scan in an emergency. Other problems, such as an abscess, a stroke or an abnormal tangle of blood vessels, can look similar on a scan, so imaging alone often cannot settle the diagnosis. A biopsy usually does. Tissue is taken either with a needle guided through a small hole in the skull or during an operation to remove the tumor. A pathologist identifies the tumor type and assigns a grade from 1 to 4: lower grades look closer to normal cells and grow slowly, while higher grades grow quickly and invade nearby tissue. The lab also tests the tumor for specific genetic changes, such as changes in the IDH (isocitrate dehydrogenase) genes or loss of parts of chromosomes 1p and 19q in gliomas, which help predict how the tumor will behave and which treatments are likely to work. When scans clearly show a slow-growing, benign-looking tumor, doctors sometimes monitor it without a biopsy. Unlike most cancers, primary brain tumors are not given a stage, because they rarely spread outside the nervous system. Their type, grade, location, genetic features and how much can be removed guide treatment instead.
Treatment depends on the tumor's type, grade and location and on the person's overall health. It is usually planned by a team that includes a neurosurgeon, a radiation oncologist and a neuro-oncologist (a cancer specialist focused on the nervous system). Surgery is often the first step. Removing as much tumor as can be taken out safely relieves pressure on the brain and provides tissue for diagnosis. For some slow-growing tumors, such as a grade 1 meningioma, complete removal may be all the treatment needed. Surgeons map the areas that control functions like speech and movement before, and sometimes during, the operation to limit damage. Some tumors sit too deep or too close to vital areas to remove fully. Some very slow-growing tumors that cause no symptoms are simply watched with regular scans, which avoids treatment side effects until treatment is actually needed. Radiation therapy uses focused high-energy beams to kill tumor cells or stop their growth. It may follow surgery to treat cells left behind, or be used when surgery is not possible. During treatment, a fitted mesh mask holds the head still. Stereotactic radiosurgery, despite its name, involves no incision: it aims a single large dose precisely at a small tumor. Chemotherapy helps for some tumor types. Temozolomide, a chemotherapy pill, is one of the drugs used for gliomas. Many drugs do not cross the protective barrier between the bloodstream and the brain well, which limits the options. Targeted drugs act on a specific feature of a tumor, which is one reason the genetic testing of the tissue matters. Bevacizumab, an infused drug that blocks the growth of new blood vessels that tumors need, is used for glioblastoma that has come back. Other treatment eases symptoms. A steroid such as dexamethasone reduces swelling around a tumor and can relieve headaches and other symptoms. Anti-seizure medicine is generally started only after a tumor has caused a seizure, rather than given to everyone as prevention. Because many of these drugs can change how chemotherapy works in the body, the team chooses one that fits the rest of treatment. When a tumor or its treatment affects the pituitary gland, hormone replacement may be needed. For tumors that are hard to control, a clinical trial may be the best option, and it is worth asking about early.
The outlook for CNS tumors varies more than for most diagnoses. Many benign tumors, once removed or controlled, cause few further problems, and some slow-growing tumors are simply monitored for years. Fast-growing malignant tumors such as glioblastoma usually cannot be removed completely and tend to return despite treatment. Prognosis depends on the tumor's type, grade, genetic features and location, how much could be removed, and the person's general health, so the most useful outlook is one the care team gives for the specific tumor. Daily life depends on which part of the nervous system was affected and on the treatment. Weakness, numbness, problems with balance, speech, vision, memory or concentration, and changes in mood or personality can come from the tumor itself or from surgery or radiation. Some effects improve during recovery, some last, and some appear years after treatment. Rehabilitation helps many people: physical and occupational therapists work on movement and everyday tasks, and speech-language pathologists on communication. It is reasonable to ask the care team which activities are safe and which are limited for now. Follow-up continues long after treatment ends. CNS tumors can come back, sometimes many years later, so regular checkups and MRI scans are scheduled, most closely in the first few months and years. Surgery or radiation near the base of the brain can affect the pituitary gland, and some people need lifelong hormone treatment overseen by an endocrinologist (a hormone specialist). Children treated for brain tumors need long-term follow-up because late effects of treatment are a particular concern. Worry about the tumor returning is very common, and counseling or a support group can help people and families carry it.
See a doctor about headaches that keep getting worse, or about changes in vision, hearing, speech, balance, strength, sensation, thinking or personality that persist or progress. Most headaches are not caused by tumors, but symptoms that don't go away deserve an explanation. Back pain together with numbness or weakness in the arms or legs that develops gradually should be evaluated promptly. Weakness or numbness in the legs that comes on suddenly or worsens quickly, numbness around the groin or buttocks, or new loss of bladder or bowel control can mean the spinal cord or its nerve roots are being compressed and needs emergency care the same day. If you are being treated or followed for a CNS tumor, contact your care team right away about any new symptom or a change in existing ones, since it can signal swelling, a treatment effect or regrowth. Report every seizure to the team, even one that stops on its own and is followed by a normal recovery. Call 911 for a first-ever seizure, a seizure lasting more than 2 to 5 minutes, another seizure starting soon after one ends, or when the person does not wake up or return to normal behavior afterward.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with CNS Neoplasms is like, what's helped you, or ask the community a question.